Tazemetostat in advanced epithelioid sarcoma with loss of...

  • Main
  • 2020 / 10
  • Tazemetostat in advanced epithelioid sarcoma with loss of...
The Lancet Oncology 2020 / 10

Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study

Gounder, Mrinal, Schöffski, Patrick, Jones, Robin L, Agulnik, Mark, Cote, Gregory M, Villalobos, Victor M, Attia, Steven, Chugh, Rashmi, Chen, Tom Wei-Wu, Jahan, Thierry, Loggers, Elizabeth T, Gupta,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(20)30451-4
Date:
October, 2020
File:
PDF, 596 KB
2020
Conversion to is in progress
Conversion to is failed